LUMOS PHARMA, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Lumos Pharma, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Lumos Pharma, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 8.65M shares, a 9.27% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 8.65M +734K +9.27% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 8.12M +81.8K +1.02% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 8.11M -76.2K -0.93% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 8.1M -165K -2% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 7.91M -461K -5.5% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 8.04M -336K -4.01% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 8.18M -175K -2.1% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 8.27M -89.4K -1.07% Dec 31, 2022 10-K 2024-03-07
Q3 2022 8.38M +17.9K +0.21% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 8.38M +20.2K +0.24% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 8.36M +26.4K +0.32% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 8.36M +52.1K +0.63% Dec 31, 2021 10-K 2023-03-07
Q3 2021 8.36M +64.1K +0.77% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 8.36M +64.1K +0.77% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 8.33M +39.4K +0.48% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 8.31M +7.13M +605% Dec 31, 2020 10-K 2022-03-11
Q3 2020 8.29M -29M -77.8% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 8.29M -29M -77.8% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 8.29M -29M -77.8% Mar 31, 2020 10-Q 2020-06-02
Q4 2019 1.18M -36.1M -96.8% Dec 31, 2019 10-K 2021-03-09
Q3 2019 37.3M +97.2K +0.26% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 37.3M +103K +0.28% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 37.3M +111K +0.3% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 37.3M +142K +0.38% Dec 31, 2018 10-K 2020-03-03
Q3 2018 37.2M +5.9M +18.8% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 37.2M +7.92M +27% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 37.2M +7.95M +27.2% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 37.1M +7.95M +27.2% Dec 31, 2017 10-K 2019-03-05
Q3 2017 31.3M +2.23M +7.66% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 29.3M +319K +1.1% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 29.2M +359K +1.24% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 29.2M +350K +1.21% Dec 31, 2016 10-K 2018-03-05
Q3 2016 29.1M +317K +1.1% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 29M +301K +1.05% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 28.9M +344K +1.21% Mar 31, 2016 10-Q 2016-04-29
Q4 2015 28.8M +833K +2.98% Dec 31, 2015 10-Q 2016-11-08
Q3 2015 28.8M +845K +3.03% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 28.7M +758K +2.72% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 28.5M +655K +2.35% Mar 31, 2015 10-Q/A 2015-08-24
Q4 2014 28M +1.41M +5.3% Dec 31, 2014 10-Q 2015-11-06
Q3 2014 27.9M +2.23M +8.66% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 27.9M +2.2M +8.57% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 27.9M +2.26M +8.82% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 26.6M +5.59M +26.6% Dec 31, 2013 10-Q 2014-11-10
Q3 2013 25.7M +4.79M +22.9% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 25.7M +4.86M +23.3% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 25.6M +4.93M +23.9% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 21M +394K +1.91% Dec 31, 2012 10-K 2014-03-12
Q3 2012 20.9M +17.2M +468% Sep 30, 2012 10-Q 2012-10-31
Q2 2012 20.8M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 20.7M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 20.6M +17M +468% Dec 31, 2011 10-K 2013-03-15
Q3 2011 3.68M Sep 30, 2011 10-Q/A 2012-01-17
Q4 2010 3.63M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.